Ginkgo Bioworks Holdings, Inc. (DNA) Q3 2024 Earnings Call Transcript
Portfolio Pulse from
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) held its Q3 2024 earnings call on November 12, 2024. Key participants included CEO Jason Kelly and CFO Mark Dmytruk, with analysts from Morgan Stanley, Goldman Sachs, Bank of America, BTIG, and TD Cowen attending.
November 13, 2024 | 3:15 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Ginkgo Bioworks held its Q3 2024 earnings call, providing insights into its financial performance and future outlook. The presence of major analysts suggests significant interest in the company's trajectory.
The earnings call is a routine event that provides updates on the company's financial performance. The participation of analysts from major financial institutions indicates a high level of interest, but without specific financial results or guidance, the immediate impact on stock price is neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100